IPO registrations (S-1, F-1) · Registrants
AYTU BIOPHARMA, INC
- SEC CIK
- 1385818 · filings on EDGAR ↗
- Former names
- AYTU BIOSCIENCE, INC (2015–2021); Rosewind CORP (2007–2015)
- Registration
- Form S-1, first filed 2015-07-01, last 2025-06-05; 12 initial registrations, 18 amendments
- Outcome
- Final prospectus filed 2016-05-04; declared effective 2015-08-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 7900 E. UNION AVENUE, SUITE 920, Denver, CO 80237
- EIN
- 47-0883144
- Ticker
- AYTU (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- AYTU BIOPHARMA, INC on the corporate pages
On this site
- Business registration: AYTU BIOPHARMA, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Aytu BioPharma, Inc. Fuzzy (name and state)
- Business registration: Aytu BioPharma, Inc. Fuzzy (name and state)
- Business registration: AYTU BIOPHARMA, INC. Fuzzy (name and state)
- Business registration: AYTU BIOPHARMA, INC. Fuzzy (name and state)
- Business registration: AYTU BIOPHARMA, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: AYTU BIOPHARMA, INC. EXACT (EIN (EXACT))
- Federal award recipient: AYTU BIOPHARMA, INC Fuzzy (name and state)
- Form D issuer: AYTU BIOSCIENCE, INC EXACT (CIK (EXACT))
- SEC filer: AYTU BIOPHARMA, INC EXACT (CIK (EXACT))
Filings 65
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2015-07-01 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001193125-15-242983 ↗ |
| 2015-07-30 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001193125-15-271130 ↗ |
| 2015-08-07 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001193125-15-282648 ↗ |
| 2015-08-10 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-15-002236 ↗ |
| 2015-10-14 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001193125-15-343855 ↗ |
| 2015-10-15 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-15-002755 ↗ |
| 2015-10-23 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-15-002862 ↗ |
| 2016-03-02 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-16-085455 ↗ |
| 2016-03-11 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-16-087646 ↗ |
| 2016-03-11 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-16-003935 ↗ |
| 2016-04-25 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-16-095926 ↗ |
| 2016-05-02 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-16-004492 ↗ |
| 2016-05-04 | 424B4 | 424B4 (final prospectus) | AYTU BIOSCIENCE, INC | 0001144204-16-098767 ↗ |
| 2016-06-17 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-16-108742 ↗ |
| 2016-06-30 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-16-005053 ↗ |
| 2016-09-02 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-16-122687 ↗ |
| 2016-09-19 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-16-005724 ↗ |
| 2016-09-21 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-16-124782 ↗ |
| 2016-10-11 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-16-127502 ↗ |
| 2016-10-25 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-16-129428 ↗ |
| 2016-10-27 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-16-129863 ↗ |
| 2016-10-27 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-16-006083 ↗ |
| 2016-10-28 | 424B4 | 424B4 (final prospectus) | AYTU BIOSCIENCE, INC | 0001144204-16-130343 ↗ |
| 2017-02-08 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-17-000323 ↗ |
| 2017-04-04 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-17-000729 ↗ |
| 2017-04-25 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-17-000933 ↗ |
| 2017-09-05 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001144204-17-046645 ↗ |
| 2017-09-22 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-17-049263 ↗ |
| 2017-09-25 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-17-049333 ↗ |
| 2017-10-20 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001144204-17-053498 ↗ |
| 2017-10-24 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-17-002766 ↗ |
| 2017-12-01 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-17-003111 ↗ |
| 2018-02-12 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001213900-18-001614 ↗ |
| 2018-02-22 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-002224 ↗ |
| 2018-02-23 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-002247 ↗ |
| 2018-02-27 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-002319 ↗ |
| 2018-02-28 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-002353 ↗ |
| 2018-03-01 | S-1MEF | S-1MEF (added securities) | AYTU BIOSCIENCE, INC | 0001213900-18-002480 ↗ |
| 2018-03-01 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-18-000520 ↗ |
| 2018-03-02 | 424B4 | 424B4 (final prospectus) | AYTU BIOSCIENCE, INC | 0001213900-18-002521 ↗ |
| 2018-09-07 | S-1 | S-1 (registration) | AYTU BIOSCIENCE, INC | 0001213900-18-012289 ↗ |
| 2018-09-25 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-012974 ↗ |
| 2018-09-28 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-013189 ↗ |
| 2018-10-03 | S-1/A | S-1/A (amendment) | AYTU BIOSCIENCE, INC | 0001213900-18-013427 ↗ |
| 2018-10-04 | S-1MEF | S-1MEF (added securities) | AYTU BIOSCIENCE, INC | 0001213900-18-013575 ↗ |
| 2018-10-04 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-18-002541 ↗ |
| 2018-10-05 | 424B4 | 424B4 (final prospectus) | AYTU BIOSCIENCE, INC | 0001213900-18-013629 ↗ |
| 2020-01-10 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-20-000067 ↗ |
| 2020-01-15 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-20-000094 ↗ |
| 2020-02-28 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-20-000446 ↗ |
| 2020-06-17 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-20-001463 ↗ |
| 2020-06-17 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-20-001464 ↗ |
| 2021-02-09 | EFFECT | EFFECT (declared effective) | AYTU BIOSCIENCE, INC | 9999999995-21-000531 ↗ |
| 2021-10-07 | EFFECT | EFFECT (declared effective) | AYTU BIOPHARMA, INC | 9999999995-21-003823 ↗ |
| 2022-06-22 | EFFECT | EFFECT (declared effective) | AYTU BIOPHARMA, INC | 9999999995-22-001844 ↗ |
| 2023-05-01 | S-1 | S-1 (registration) | AYTU BIOPHARMA, INC | 0001104659-23-054549 ↗ |
| 2023-06-05 | S-1/A | S-1/A (amendment) | AYTU BIOPHARMA, INC | 0001104659-23-068133 ↗ |
| 2023-06-08 | EFFECT | EFFECT (declared effective) | AYTU BIOPHARMA, INC | 9999999995-23-001685 ↗ |
| 2023-06-12 | 424B4 | 424B4 (final prospectus) | AYTU BIOPHARMA, INC | 0001104659-23-070432 ↗ |
| 2024-10-15 | EFFECT | EFFECT (declared effective) | AYTU BIOPHARMA, INC | 9999999995-24-003186 ↗ |
| 2025-06-02 | S-1 | S-1 (registration) | AYTU BIOPHARMA, INC | 0001437749-25-019189 ↗ |
| 2025-06-05 | S-1/A | S-1/A (amendment) | AYTU BIOPHARMA, INC | 0001437749-25-019550 ↗ |
| 2025-06-05 | EFFECT | EFFECT (declared effective) | AYTU BIOPHARMA, INC | 9999999995-25-001849 ↗ |
| 2025-06-06 | S-1MEF | S-1MEF (added securities) | AYTU BIOPHARMA, INC | 0001437749-25-019599 ↗ |
| 2025-06-09 | 424B4 | 424B4 (final prospectus) | AYTU BIOPHARMA, INC | 0001437749-25-019761 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| WIEGAND JAMES B | Director,Officer,TenPercentOwner | President | 1 | 2014 | |
| Disbrow Joshua R. | Director,Officer; Officer | Chief Executive Officer | 30 | 2015–2026 | |
| Gould Gregory A | Officer | Chief Financial Officer | 7 | 2015–2017 | |
| MACALUSO MICHAEL | Director | 9 | 2015–2021 | ||
| Disbrow Jarrett | Director,Officer; Officer; OfficerOther | Chief Business Officer; Chief Operating Officer | 20 | 2015–2026 | |
| McGrael Jonathan H | Officer | Vice President of Sales; VP of Commercial Operations | 3 | 2015–2016 | |
| Ampio Pharmaceuticals, Inc. | TenPercentOwner | 1 | 2015 | ||
| DOCKERY CARL | Director | 17 | 2016–2026 | ||
| Cantrell Gary | Director | 12 | 2016–2022 | ||
| Donofrio John Jr. | Director | 12 | 2016–2026 | ||
| Green David A | Officer | Chief Financial Officer | 7 | 2017–2020 | |
| Mehta Ketan Bhupatrai | Director; Officer | Chief Financial Officer | 4 | 2018–2020 | |
| ARMISTICE CAPITAL, LLC | Director; Director,TenPercentOwner; TenPercentOwner | 11 | 2019–2021 | ||
| Armistice Capital Master Fund Ltd. | Director; TenPercentOwner | 11 | 2019–2021 | ||
| Boyd Steven | Director; Director,TenPercentOwner; TenPercentOwner | 11 | 2019–2021 | ||
| Cerecor Inc. | TenPercentOwner | 2 | 2020 | ||
| Hecht Beth | Director | 2 | 2021 | ||
| McLaughlin Gerald W. | Director | 2 | 2021 | ||
| Eisenstadt Richard I | Officer | Chief Financial Officer | 2 | 2021 | |
| Oki Mark K | Officer | Chief Financial Officer | 5 | 2022–2023 | |
| LIU VIVIAN H | Director | 8 | 2022–2026 | ||
| BROOKE CHRISTOPHER | Officer | Chief Operating Officer | 2 | 2022–2023 | |
| PYSZCZYMUKA GREG | Officer | Chief Commercial Officer; Chief Commerical Officer | 16 | 2022–2026 | |
| JAIN ABHINAV | Director | 6 | 2023–2026 | ||
| Harkey Wilmot B. | TenPercentOwner | 3 | 2023–2025 | ||
| Mack Daniel | TenPercentOwner | 3 | 2023–2025 | ||
| Nantahala Capital Management, LLC | TenPercentOwner | 3 | 2023–2025 | ||
| Selhorn Ryan J | Officer | Chief Financial Officer | 5 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-10-31 | AYTU BIOSCIENCE, INC | Pharmaceuticals | $10,000,000 | $10,000,000 | 2 | 1 |
| 2017-08-24 | AYTU BIOSCIENCE, INC | Pharmaceuticals | $11,839,995 | $11,839,995 | 70 | 1 |
| 2017-05-16 | AYTU BIOSCIENCE, INC | Pharmaceuticals | Indefinite | $1,750,000 | 16 | 1 |
| 2015-08-05 | AYTU BIOSCIENCE, INC | Pharmaceuticals | $6,000,000 | $5,175,000 | 96 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.